Emerging like a significant game-changer in the area against excess weight, Retatrutide is quickly gaining focus. This novel dual agonist – acting on both GLP-1 and GIP receptors – exhibits remarkable efficacy in research trials. Initial findings point that Retatrutide could deliver more weight r